Novo Nordisk A/S Class B
No hay operaciones
Títulos de deuda corporativa
A continuación se muestra la lista de bonos de Novo Nordisk A/S Class B, ordenados según su rendimiento al vencimiento. Los inversores suelen optar por los bonos de una empresa por su mayor estabilidad en períodos de volatilidad del mercado. Analice los precios, los rendimientos y otras estadísticas para tomar decisiones de inversión fiables.
Símbolo | YTM % | Volumen | Precio % | Cupón % | Fecha de vencimiento | Imp. pendiente | Valor nominal | Imp. mín. denom. | Emisor |
|---|---|---|---|---|---|---|---|---|---|
| XXS323295972Novo Nordisk Finance (Netherlands) BV 4.0% 20-NOV-2045 | 4,26% | 0 | 96,53% | 4,000% | 2045-11-20 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323295590Novo Nordisk Finance (Netherlands) BV 3.625% 20-FEB-2038 | 3,81% | 0 | 98,18% | 3,625% | 2038-02-20 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255582Novo Nordisk Finance (Netherlands) BV 3.625% 27-MAY-2037 | 3,73% | 0 | 98,96% | 3,625% | 2037-05-27 | 1,25 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323294453Novo Nordisk Finance (Netherlands) BV 3.375% 20-FEB-2035 | 3,56% | 0 | 98,57% | 3,375% | 2035-02-20 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282046075Novo Nordisk Finance (Netherlands) BV 3.375% 21-MAY-2034 | 3,47% | 0 | 99,26% | 3,375% | 2034-05-21 | 1,35 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255353Novo Nordisk Finance (Netherlands) BV 3.125% 27-MAY-2033 | 3,29% | 0 | 98,93% | 3,125% | 2033-05-27 | 900 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323293716Novo Nordisk Finance (Netherlands) BV 3.0% 20-FEB-2032 | 3,15% | 0 | 99,17% | 3,000% | 2032-02-20 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282045567Novo Nordisk Finance (Netherlands) BV 3.25% 21-JAN-2031 | 3,06% | 0 | 100,89% | 3,250% | 2031-01-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255329Novo Nordisk Finance (Netherlands) BV 2.875% 27-AUG-2030 | 3,00% | 0 | 99,43% | 2,875% | 2030-08-27 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| 2,89% | 0 | 94,02% | 1,375% | 2030-03-31 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV | |
| XXS300255299Novo Nordisk Finance (Netherlands) BV 2.375% 27-MAY-2028 | 2,74% | 0 | 99,16% | 2,375% | 2028-05-27 | 1,45 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282045460Novo Nordisk Finance (Netherlands) BV 3.125% 21-JAN-2029 | 2,67% | 0 | 101,30% | 3,125% | 2029-01-21 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS323292124Novo Nordisk Finance (Netherlands) BV 2.5% 20-FEB-2029 | 2,66% | 0 | 99,53% | 2,500% | 2029-02-20 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS282044994Novo Nordisk Finance (Netherlands) BV 3.375% 21-MAY-2026 | 2,61% | 0 | 100,28% | 3,375% | 2026-05-21 | 1,3 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| 2,56% | 0 | 94,33% | 0,125% | 2028-06-04 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV | |
| 2,39% | 0 | 97,86% | 1,125% | 2027-09-30 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV | |
| XXS323292027Novo Nordisk Finance (Netherlands) BV FRN 20-NOV-2027 | — | 0 | 100,01% | 2,251% | 2027-11-20 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |
| XXS300255213Novo Nordisk Finance (Netherlands) BV FRN 27-MAY-2027 | — | 0 | 99,76% | 2,366% | 2027-05-27 | 1,4 B EUR | 1.000,00 EUR | 100.000,00 EUR | Novo Nordisk Finance (Netherlands) BV |